Search Within

Gregory J Riely

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (57)
  2. Meeting Abstract (27)
  3. Conference Paper (1)
Groups
  1. Department of Medicine (85)
  2. Sloan Kettering Institute Postdocs (85)
  3. Solid Tumor Oncology Division (85)
  4. Thoracic Oncology (85)
  5. GSK Faculty (80)
  6. Department of Pathology and Laboratory Medicine (76)

More Groups

People
  1. Marc Ladanyi (60)
  2. Mark Kris (45)
  3. Charles Rudin (40)
  4. Helena Yu (30)
  5. Alexander Drilon (29)
  6. Maria Arcila (28)

More People

Years
  1. 2024 (6)
  2. 2023 (14)
  3. 2022 (8)
  4. 2021 (5)
  5. 2020 (5)
  6. 2019 (13)

More Years

Publications
  1. Journal of Thoracic Oncology (16)
  2. Journal of Clinical Oncology (15)
  3. Clinical Cancer Research (14)
  4. Annals of Oncology (5)
  5. JCO Precision Oncology (5)
  6. Cancer Discovery (4)

More Publications

Publishers
  1. American Association for Cancer Research (23)
  2. American Society of Clinical Oncology (20)
  3. Elsevier Inc. (16)
  4. Nature Publishing Group (8)
  5. Oxford University Press (6)
  6. Cell Press (2)

More Publishers

Results (85)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prospective comprehensive molecular characterization of lung adenocarcinomas for efficient patient matching to approved and emerging therapies
    Journal Article

    Jordan, E. J.; Kim, H. R.; Arcila, M. E.; Barron, D.; Chakravarty, D.; Gao, J. J.; Chang, M. T.; Ni, A.; Kundra, R.; Jonsson, P.; more...
    Cancer Discovery (2017)

    Fulltext@MSK | Save
  • A Phase 1/2 trial of ruxolitinib and erlotinib in patients with EGFR-mutant lung adenocarcinomas with acquired resistance to erlotinib
    Journal Article

    Yu, H. A.; Perez, L.; Chang, Q.; Gao, S. P.; Kris, M. G.; Riely, G. J.; Bromberg, J.
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Basket trials in oncology: A trade-off between complexity and efficiency
    Journal Article

    Cunanan, K. M.; Gonen, M.; Shen, R.; Hyman, D. M.; Riely, G. J.; Begg, C. B.; Iasonos, A.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • MDM2 amplification (Amp) to mediate cabozantinib resistance in patients (Pts) with advanced RET-rearranged lung cancers
    Meeting Abstract

    Somwar, R.; Smith, R.; Hayashi, T.; Ishizawa, K.; Charen, A. S.; Khodos, I.; Mattar, M.; He, J.; Balasubramanian, S.; Stephens, P.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Cabozantinib in patients with advanced RET-rearranged non-small-cell lung cancer: an open-label, single-centre, phase 2, single-arm trial
    Journal Article

    Drilon, A.; Rekhtman, N.; Arcila, M.; Wang, L.; Ni, A.; Albano, M.; Van Voorthuysen, M.; Somwar, R.; Smith, R. S.; Montecalvo, J.; more...
    Lancet Oncology (2016)

    Fulltext@MSK | Save
  • Clinical outcomes with pemetrexed-based systemic therapies in RET-rearranged lung cancers
    Journal Article

    Drilon, A.; Bergagnini, I.; Delasos, L.; Sabari, J.; Woo, K. M.; Plodkowski, A.; Wang, L.; Hellmann, M. D.; Joubert, P.; Sima, C. S.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • A novel crizotinib-resistant solvent-front mutation responsive to cabozantinib therapy in a patient with ROS1-rearranged lung cancer
    Journal Article

    Drilon, A.; Somwar, R.; Wagner, J. P.; Vellore, N. A.; Eide, C. A.; Zabriskie, M. S.; Arcila, M. E.; Hechtman, J. F.; Wang, L.; Smith, R. S.; more...
    Clinical Cancer Research (2016)

    Fulltext@MSK | Save
  • Clinical outcomes with pemetrexed-based systemic therapy in RET-rearranged lung cancers
    Meeting Abstract

    Drilon, A.; Bergagnini, I.; Delasos, L.; Sima, C. S.; Smith, R.; Somwar, R.; Riely, G. J.; Kris, M. G.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Phase II study of cabozantinib for patients with advanced RET-rearranged lung cancers
    Meeting Abstract

    Drilon, A. E.; Sima, C. S.; Somwar, R.; Smith, R.; Ginsberg, M. S.; Riely, G. J.; Rudin, C. M.; Ladanyi, M.; Kris, M. G.; Rizvi, N. A.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Acquired resistance to epidermal growth factor receptor (EGFR) kinase inhibitors associated with a novel T854A mutation in a patient with EGFR-mutant lung adenocarcinoma
    Meeting Abstract

    Bean, J.; Riely, G. J.; Balak, M.; Marks, J. L.; Ladanyi, M.; Miller, V. A.; Pao, W.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save